Can you provide the average price target for NEVRO CORP stock?
19 analysts have analysed NVRO and the average price target is 8.87 USD. This implies a price increase of 51.87% is expected in the next year compared to the current price of 5.84.
NEVRO CORP (NVRO) Forecast, Price Target & Analyst Ratings
NYSE:NVRO • US64157F1030
Current stock price
5.84 USD
0 (0%)
At close:
5.8401 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEVRO CORP (NVRO).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 5, 2025
- Period
- Q1 / 2025
- EPS Estimate
- -$0.79
- Revenue Estimate
- 95.437M
Price Target Details & History
Consensus Price Target and Range
Mean target
$8.87
Upside
+ 51.87%
From current price of $5.84 to mean target of $8.87, Based on 19 analyst forecasts
Low
$4.04
Median
$5.97
High
$42.00
Price Target Revisions
1 Month
0.00%
3 Months
10.28%
Price Target Summary
19 Wall Street analysts provided a forecast for the next 12 months for NVRO. The average price target is 8.87 USD. This implies a price increase of 51.87% is expected in the next year compared to the current price of 5.84.
The average price target has been revised upward by 10.28% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
53.68%
NVRO was analyzed by 19 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about NVRO.
In the previous month the buy percentage consensus was at a similar level.
NVRO was analyzed by 19 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-02-07 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-02-07 | Piper Sandler | Upgrade | Underweight -> Neutral |
| 2024-12-18 | Truist Securities | Maintains | Hold -> Hold |
| 2024-12-11 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-12-11 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-12-09 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2024-12-03 | Wells Fargo | Reiterate | Equal-Weight |
| 2024-12-02 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2024-11-12 | JMP Securities | Reiterate | Market Perform |
| 2024-11-12 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-11-12 | Baird | Maintains | Neutral -> Neutral |
| 2024-11-12 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2024-11-12 | Piper Sandler | Maintains | Underweight -> Underweight |
| 2024-10-01 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-08-09 | Citigroup | Upgrade | Sell -> Neutral |
| 2024-08-08 | Wolfe Research | Upgrade | Underperform -> Peer Perform |
| 2024-08-08 | Truist Securities | Maintains | Hold -> Hold |
| 2024-08-07 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-08-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-08-07 | Wells Fargo | Downgrade | Equal-Weight -> Underweight |
| 2024-08-07 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2024-08-07 | Baird | Maintains | Neutral -> Neutral |
| 2024-08-07 | Piper Sandler | Maintains | Underweight -> Underweight |
| 2024-07-16 | Truist Securities | Maintains | Hold -> Hold |
| 2024-07-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 5, 2025
- Period
- Q1 / 2025
- EPS Estimate
- -$0.79
- Revenue Estimate
- 95.437M
- Revenue Q2Q
- -6.34%
- EPS Q2Q
- -36.82%
- Number of Analysts
- 14
Next Earnings Revisions
Revenue (1 Month)
-1.34%
Revenue (3 Months)
-1.97%
EPS (1 Month)
0.00%
EPS (3 Months)
6.89%
Next Earnings Summary
NVRO is expected to report earnings on 5/5/2025. The consensus EPS estimate for the next earnings is -0.79 USD and the consensus revenue estimate is 95.44M USD.
The next earnings revenue estimate has been revised downward by 1.97% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 406.4M 5.04% | 425.174M 4.62% | 408.518M -3.92% | 414.8M 1.54% | 432.94M 4.37% | 454.79M 5.05% | 491.78M 8.13% | 513.52M 4.42% | 525.4M 2.31% | |
| EBITDA YoY % growth | -92.62M -7.67% | -92.258M 0.39% | -65.603M 28.89% | -14.436M 78.00% | 3.386M 123.46% | 11.322M 234.38% | 30.549M 169.82% | 45.39M 48.58% | 56.202M 23.82% | |
| EBIT YoY % growth | -98.8M -8.69% | -99.308M -0.51% | -76.502M 22.96% | -87.574M -14.47% | -72.152M 17.61% | -64.566M 10.51% | -49.606M 23.17% | -36.516M 26.39% | -13.26M 63.69% | |
| Operating Margin | -24.31% | -23.36% | -18.73% | -21.11% | -16.67% | -14.20% | -10.09% | -7.11% | -2.52% | |
| EPS YoY % growth | -0.01 99.69% | -2.57 -25,600.00% | -1.92 25.29% | -2.49 -29.92% | -2.17 12.90% | -1.99 8.33% | -1.47 26.25% | -1.06 27.78% | -0.79 25.96% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.79 -36.82% | -0.59 -10.47% | -0.52 -27.87% | -0.52 -30.82% | -0.72 8.74% | -0.49 15.94% | -0.43 18.29% | -0.43 17.64% |
| Revenue Q2Q % growth | 95.437M -6.34% | 105.06M 0.86% | 103.64M 6.94% | 114.57M 8.55% | 100.59M 5.40% | 109.85M 4.56% | 103.97M 0.32% | 117.4M 2.47% |
| EBITDA Q2Q % growth | -14.448M 56.28% | -1.712M 91.26% | -210.324K 96.30% | -260.1K 88.70% | -6.42M 55.57% | 9.826M 674.10% | 18.399M 8,847.93% | 9.098M 3,597.89% |
| EBIT Q2Q % growth | -30.276M 15.51% | -19.45M 22.58% | -16.75M -20.80% | -17.759M -34.54% | -26.125M 13.71% | -11.565M 40.54% | -6.609M 60.54% | -9.582M 46.04% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-1.23%
EPS Next 5 Year
7.68%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
3.23%
Revenue Next 5 Year
4.43%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
28.25%
EBIT Next 5 Year
19.53%
NEVRO CORP / NVRO Forecast FAQ
When does NEVRO CORP (NVRO) report earnings?
NEVRO CORP (NVRO) will report earnings on 2025-05-05, after the market close.
What are the consensus estimates for NEVRO CORP (NVRO) next earnings?
The consensus EPS estimate for the next earnings of NEVRO CORP (NVRO) is -0.79 USD and the consensus revenue estimate is 95.44M USD.
Can you provide the consensus rating for NEVRO CORP stock?
The consensus rating for NEVRO CORP (NVRO) is 53.6842 / 100 . This indicates that analysts generally have a neutral outlook on the stock.